相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Consumption of Milk and alternatives decreased among Canadians from 2004 to 2015: evidence from the Canadian community health surveys
Hassan Vatanparast et al.
BMC NUTRITION (2021)
Understanding the Biological Activities of Vitamin D in Type 1 Neurofibromatosis: New Insights into Disease Pathogenesis and Therapeutic Design
Claudia Riccardi et al.
CANCERS (2020)
Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1
Antonia Assunto et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Trabecular Bone Score (TBS) and Bone Metabolism in Patients Affected with Type 1 Neurofibromatosis (NF1)
Marcello Filopanti et al.
CALCIFIED TISSUE INTERNATIONAL (2019)
Prevalence of neurofibromatosis type 1 in the Finnish population
Roope A. Kallionpaa et al.
GENETICS IN MEDICINE (2018)
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848
Magdalena Koczkowska et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Height Growth Impairment in Children With Neurofibromatosis Type 1 Is Characterized by Decreased Pubertal Growth Velocity in Both Sexes
Nicholas R. Zessis et al.
JOURNAL OF CHILD NEUROLOGY (2018)
Insulin and osteocalcin: further evidence for a mutual cross-talk
Francesco L. Bilotta et al.
ENDOCRINE (2018)
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1 Multidisciplinary Recommendations for Care
Robert A. Avery et al.
OPHTHALMOLOGY (2017)
UK clinical guideline for the prevention and treatment of osteoporosis
J. Compston et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL DENSITOMETRY (2016)
Arg1809 substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1
Claudia Santoro et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas
Valentina Pinna et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?
Eric Pasmant et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
The generalized bone phenotype in children with neurofibromatosis 1: A sibling matched case-control study
Linlea Armstrong et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Mechanosensation and transduction in osteocytes
Jenneke Klein-Nulend et al.
BONE (2013)
NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience
Audrey Sabbagh et al.
HUMAN MUTATION (2013)
Vitamin D in the Healthy European Paediatric Population
Christian Braegger et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2013)
Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease)
Luigi Petramala et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2012)
Bone mineral density in children and young adults with neurofibromatosis type 1
Maya B. Lodish et al.
ENDOCRINE-RELATED CANCER (2012)
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
Lingling Xian et al.
NATURE MEDICINE (2012)
Multiple Increased Osteoclast Functions in Individuals with Neurofibromatosis Type 1
David A. Stevenson et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review
Paul H. Lee et al.
INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY (2011)
NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype
Eric Pasmant et al.
HUMAN MUTATION (2010)
Quantitative Ultrasound and Dual-Energy X-ray Absorptiometry in Children and Adolescents With Neurofibromatosis of Type 1
Carla Caffarelli et al.
JOURNAL OF CLINICAL DENSITOMETRY (2010)
High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1
S. Seitz et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)
T. Tucker et al.
JOURNAL OF MEDICAL GENETICS (2009)
Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1
Ozgur Duman et al.
BRAIN & DEVELOPMENT (2008)
Generalized metabolic bone disease in neurofibromatosis type I
Nicola Brunetti-Pierri et al.
MOLECULAR GENETICS AND METABOLISM (2008)
IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone
Yongmei Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Multiple roles for neurofibromin in skeletal development and growth
Mateusz Kolanczyk et al.
HUMAN MOLECULAR GENETICS (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Neuro-fibromatosis 1 and neuro-fibromatosis 2: a twenty first century perspective
Rosalie E. Ferner
LANCET NEUROLOGY (2007)
Hyperactivation of p21ras and PI3K cooperate to after murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions
Feng-Chun Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1
M. Lammert et al.
JOURNAL OF MEDICAL GENETICS (2006)
Neurofibromin:: a general outlook
A. B. Trovo-Marqui et al.
CLINICAL GENETICS (2006)
Decreased bone mineral density in patients with neurofibromatosis 1
M Lammert et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Decreased bone mineral density and content in neurofibromatosis type 1:: Lowest local values are located in the load-carrying parts of the body
T Kuorilehto et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Growth in North American white children with neurofibromatosis 1 (NF1)
J Szudek et al.
JOURNAL OF MEDICAL GENETICS (2000)
分享论文
